10-Title: Haemolytic complement activity depicting the innate immune status of cattle in Chhattisgarh
Authors: Govina Dewangan, SD Hirpurkar, Deepak Kumar Kashyap, Devesh Kumar Giri and RC Ghosh
Source: Ruminant Science (2015)-4(2):175-176.
How to cite this manuscript: Dewangan Govina, Hirpurkar SD, Kashyap Deepak Kumar, Giri Devesh Kumar and Ghosh RC (2015). Haemolytic complement activity depicting the innate immune status of cattle in Chhattisgarh. Ruminant Science 4(2):175-176.
Innate immunity plays an important role in host defense against diseases. Complement is an important and well known component of innate immunity. Haemolytic complement activity (CH50 assay) estimation is an important tool for the assessing innate immune status. A comparative study was performed for evaluation of innate immunity status based on the haemolytic complement activity i.e. CH50 assay. For the comparative study Non-descript (ND) and Sahiwal (S) cattle of Chhattisgarh (CG) were selected and divided into 4 groups viz ND-I (6 months-2 years age), ND-II (above 2 years), S-I (6 months-2 years age) and S-II (above 2 years) comprising of 8 animals in each group. The sequential activation of the classical pathway component (C1 through C9) result into lysis of sheep erythrocytes (SRBC) that have been sensitized with optimal amounts of rabbit anti-sheep erythrocyte antibodies i.e. hemolysin (anti-SRBC). Complement was quantified by determining the serum dilution required to lyse 50% of the cells in the assay mixture. The mean (±SE) values of CH50 for ND-I, ND-II, S-I and S-II groups were 166.75±1.30 CH50 U/ml, 174.25±0.75 CH50 U/ml, 171.62±0.68 CH50 U/ml and 184.50±0.59 CH50 U/ml, respectively. ND calves and adults possessed significantly (P<0.01) lower activity than Sahiwal cattle. The results indicated that in Chhattisgarh Sahiwal having high innate immunity level as compare to the Non-descript cattle.
Barta O and Barta V (1975). Chicken (Gallus gallus) hemolytic complement: optimal conditions for its titration. Immunological investigation 4(4):337-351.
Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM and Strober W (1994). Current Protocols in Immunology. John Wiley and Sons. USA.
Costabile M (2010). Measuring the 50% haemolytic complement (CH50) activity of serum. Journal of Visualized Experiments. http://www.jove.com.
Dewangan G, Hirpurkar SD, Giri DK and Kashyap DK (2014). Assessment of innate immunity by phagocytic activity in non-descript and Sahiwal cattle in Chhattisgarh. Veterinary World 7(11):943-947.
Olitzky I (1968). Stadardized, automated procedure for measuremet of serum hemolytic complement activity. Applied Microbiology 16(11):1635-1639.
Potter BJ, Trueman AM and Jones EA (1973). Serum complement in chronic liver disease. Gut 14(6):451-456.
Renshaw HW, Eckblad WP, Tassinari PD and Everson DO (1978). Levels of total haemolytic complement activity in paired dairy cow-newborn calf sera. Immunology 34:801-805.
Singh S, Goel MC and Monga DP (1993). Studies on activation and levels of haemolytic complement of buffalo (Bubalus bubalis). III. C3 haemolytic activity in health and chronic disease. Veterinary Immunology and Immunopathology 35:393-398.
Snedecor GW and Cochran WG (1994). Statistical Methods. 8th Edn, Iowa State University Press Ames, Iowa, USA
Townes AL (1967). Complement levels in disease. Johns Hopkins University Medical Journal 120:337-343.
Verhagen C Hoekzema R and Kijlstra A (1994). Human corneal extract enhances serum complement activity. Investigative ophthalmology and visual science 35(1):236-241